The innovation also has the potential to detect other diseases in livestock, in addition to detecting up to 200 types of cancers
Photo: Toowongsa/Adobe Stock
Base Molecular Resonance Technologies (BMRT), a startup specializing in advanced detection technology, has developed a novel tool that can noninvasively detect poultry infected with avian influenza. The technology can also be used to detect up to 200 types of cancers and other diseases, drugs, gunpowder, and other substances, according to a recent announcement by BMRT.1
The technology—Base Molecular Resonance (BMR)—can detect particle interactions at subatomic levels using resonant frequencies. The innovation uses scanning technology that can detect any compound or biological substance, including any element on the periodic table, as well as various cancers and avian influenza based on molecular structure.1,2
“The non-invasive, harmless, and instant scan has broad implications in cancer diagnostics, public safety, law enforcement, security, and military services,” wrote BMRT in a news release.1
The tool’s new application for detecting animals infected with avian influenza can help prevent the mass slaughter of poultry amid avian influenza outbreaks, as BMR has the ability to differentiate infected birds from healthy ones instantaneously, according to the company.1 "Right now, millions of chickens are being slaughtered out of fear rather than necessity. Our technology eliminates that uncertainty. With a simple scan, we can pinpoint infected animals with 100% accuracy, allowing farmers and regulators to respond with surgical precision instead of widespread devastation,” Robert “Bo” Short, co-founder and CEO of BMRT, said in a news release.1 “This is a major step forward for global food security, animal welfare, and the agricultural economy."
More than 166 million birds, including chickens and turkeys, have been slaughtered in the United States since the start of the avian influenza outbreak, with many of these birds being healthy.1 According to BMRT, testing data suggest that only 5% to 10% of these animals would have likely tested positive for avian influenza.1 More than 20 million egg-laying chickens were culled in the only the last quarter, costing poultry farmers hundreds of millions of dollars, affecting food production and driving egg prices, and putting a strain on supply chains.1
Last year, the company announced that a study from York St John University’s Center for Applied Innovation in York, England, confirmed BMR had 100% accuracy in detecting cancerous tissues, nuclear elements, gunpowder, and more, in blind and double-blind tests.3 The research was led by Phillippe B. Wilson, PhD, PGCHE, president-elect of the Comparative Medicine Council at the Royal Society of Medicine and associate pro vice-chancellor for Innovation and Knowledge Exchange and professor of One Health at York St John University.3
“The same precision and reliability now apply to disease detection in the agricultural industry, making it possible to safeguard global food supplies with unprecedented efficiency,” wrote BMRT in its most recent announcement.1
According to BMRT, their BMR technology can also be adapted to detect diseases in cattle, swine, and other livestock, offering a valuable tool in preventing major outbreaks, including bovine spongiform encephalopathy, African swine fever, and foot-and-mouth disease.1
"Bird flu is just the beginning. We can detect disease in livestock at the molecular level before symptoms even appear, allowing for rapid intervention that safeguards the food supply and protects farmers from catastrophic losses,” said Lee Duke, co-founder and president of BMRT, in a company release.1 “This is the future of disease detection."
References